ТРОМБОЗ ГЛУБОКИХ ВЕН У ПАЦИЕНТКИ С БОЛЕЗНЬЮ ВИЛЛЕБРАНДА

В. А. Елыкомов, А. Н. Копылов
{"title":"ТРОМБОЗ ГЛУБОКИХ ВЕН У ПАЦИЕНТКИ С БОЛЕЗНЬЮ ВИЛЛЕБРАНДА","authors":"В. А. Елыкомов, А. Н. Копылов","doi":"10.17650/1818-8338-2016-10-2-50-54","DOIUrl":null,"url":null,"abstract":"Objective: to identify the possible factors of thrombogenic risk and ways of its prevention in patients with von Willebrand disease. Case description. Patient X., 42 years old, who suffers from von Willebrand disease type 3 with 5-years of age. Asked on reception to the traumatologist in the polyclinic of the Regional Hospital with pain in the left hip joint. Recommended planned operative treatment in the Altai Regional Clinical Hospital. Preoperative preparation included the infusion of concentrate of von Willebrand factor and coagulation factor VIII. Operation – cement total arthroplasty of the left hip joint. In the postoperative period analgesic treatment, elastic compression of the lower extremities, iron supplements, also conducted infusion of concentrate of von Willebrand factor and coagulation factor VIII for 20 days and thromboprophylactic with dabigatran. On the 3rd day after the operation the patient revealed deep vein thrombosis of the femoral segment (floating clot). Results. The patient was operated for emergency indications in the Department of endovascular surgery – installation of venous cava filter “Volan”. Dabigatran is cancelled, appointed clexane for 3 months. In our clinical example the patient lacked risk factors of pulmonary embolism as obesity, age, smoking, prolonged immobilization, estrogen therapy. Overdose of factor VIII were not observed – the level of factor did not exceed 135 % on transfusions. At the same time, the patient was found polymorphisms in the genes ITGA2, FGB, MTHFR, MTR – heterozygote, MTRR – mutant homozygote, which may indicate the genetic factors of thrombogenic risk. Also a significant risk factor was massive surgical intervention (total hip replacement). Despite preventive measures (elastic compression, thromboprophylactic dabigatran, early activation) we cannot to avoid thrombotic complications. Conclusion. This article presents a case demonstrating a thrombotic complication in patients with von Willebrand disease type 3 in the postoperative period of total hip arthroplasty. It is shown that despite preventive measures, she developed a very rare von Willebrand disease the phenomenon of deep vein thrombosis, bleeding was not observed. Pulmonary embolism was avoided by the installation of cava filter.","PeriodicalId":82998,"journal":{"name":"The Clinician","volume":"10 1","pages":"50-54"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Clinician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/1818-8338-2016-10-2-50-54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: to identify the possible factors of thrombogenic risk and ways of its prevention in patients with von Willebrand disease. Case description. Patient X., 42 years old, who suffers from von Willebrand disease type 3 with 5-years of age. Asked on reception to the traumatologist in the polyclinic of the Regional Hospital with pain in the left hip joint. Recommended planned operative treatment in the Altai Regional Clinical Hospital. Preoperative preparation included the infusion of concentrate of von Willebrand factor and coagulation factor VIII. Operation – cement total arthroplasty of the left hip joint. In the postoperative period analgesic treatment, elastic compression of the lower extremities, iron supplements, also conducted infusion of concentrate of von Willebrand factor and coagulation factor VIII for 20 days and thromboprophylactic with dabigatran. On the 3rd day after the operation the patient revealed deep vein thrombosis of the femoral segment (floating clot). Results. The patient was operated for emergency indications in the Department of endovascular surgery – installation of venous cava filter “Volan”. Dabigatran is cancelled, appointed clexane for 3 months. In our clinical example the patient lacked risk factors of pulmonary embolism as obesity, age, smoking, prolonged immobilization, estrogen therapy. Overdose of factor VIII were not observed – the level of factor did not exceed 135 % on transfusions. At the same time, the patient was found polymorphisms in the genes ITGA2, FGB, MTHFR, MTR – heterozygote, MTRR – mutant homozygote, which may indicate the genetic factors of thrombogenic risk. Also a significant risk factor was massive surgical intervention (total hip replacement). Despite preventive measures (elastic compression, thromboprophylactic dabigatran, early activation) we cannot to avoid thrombotic complications. Conclusion. This article presents a case demonstrating a thrombotic complication in patients with von Willebrand disease type 3 in the postoperative period of total hip arthroplasty. It is shown that despite preventive measures, she developed a very rare von Willebrand disease the phenomenon of deep vein thrombosis, bleeding was not observed. Pulmonary embolism was avoided by the installation of cava filter.
willebrand患者深静脉血栓形成
目的:探讨血管性血友病患者血栓形成危险的可能因素及预防方法。案例描述。病人X, 42岁,患有血管性血友病3型,5岁。由于左髋关节疼痛,在接待地区医院综合诊所的创伤科医生时被问到。建议在阿尔泰地区临床医院计划手术治疗。术前准备包括静脉滴注血管性血友病因子和凝血因子VIII浓缩液。手术-左髋关节骨水泥全髋关节置换术。术后镇痛、下肢弹性压迫、补铁,同时给予血管性血友病因子、凝血因子VIII浓缩物输注20天,达比加群预防血栓形成。术后第3天患者发现股段深静脉血栓形成(浮凝块)。结果。患者在血管内外科急诊指征-安装静脉腔过滤器“Volan”。达比加群被取消,指定清洁3个月。在我们的临床病例中,患者缺乏肺栓塞的危险因素,如肥胖,年龄,吸烟,长期固定,雌激素治疗。未观察到因子VIII过量-输血时因子水平不超过135%。同时发现患者ITGA2、FGB、MTHFR、MTR -杂合子、MTRR -突变纯合子基因多态性,可能提示血栓形成风险的遗传因素。另外一个重要的危险因素是大规模的手术干预(全髋关节置换术)。尽管采取预防措施(弹性压缩,血栓预防达比加群,早期激活),我们不能避免血栓并发症。结论。这篇文章提出了一个病例显示血栓性并发症的患者血管性血友病3型在全髋关节置换术后的时期。结果显示,尽管采取了预防措施,她还是患上了一种非常罕见的血管性血友病,出现了深静脉血栓的现象,没有观察到出血。肺腔过滤器的安装避免了肺栓塞。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信